GVSAP and Biocytogen Boost India's Biopharma Innovation with Expanded Collaboration
Published on: Feb. 5, 2026, 3:03 p.m. | Source: Devdiscourse
The GV Safety Assessment Platform partners with Biocytogen to enhance India's biotech research capabilities. The expanded collaboration offers pharmacology services and cell line access, fostering efficient drug discovery. This initiative underscores India's evolving biopharma landscape and elevates the nation's preclinical research standards.
